John A. Roush - 10 Dec 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role: Director
Signature: /s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol: LMAT
Transactions as of: 10 Dec 2025
Net transactions value: $0
Form type: 4
Filing time: 11 Dec 2025, 18:07:35 UTC
Previous filing: 10 Dec 2025
Next filing: 15 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Roush John A	Director	C/O LEMAITRE VASCULAR, 63 SECOND AVENUE, BURLINGTON	/s/ Laurie A. Churchill, Attorney-in-fact	11 Dec 2025	0001308225

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LMAT	Common Stock	Award	$0	+533	+18%	$0.000000	3,455	10 Dec 2025	Direct	F1
holding	LMAT	Common Stock						181	10 Dec 2025	Indirect through spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LMAT	Stock Option (Right to Buy)	Award	$0	+3,431		$0.000000	3,431	10 Dec 2025	Common Stock	3,431	$83.66	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on 12/1/2026, with the balance vesting in equal annual installments over the remaining two years.
F2	This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.